Global Bioenergies

Equities

ALGBE

FR0011052257

Advanced Medical Equipment & Technology

Real-time Euronext Paris 09:16:18 2024-03-28 am EDT 5-day change 1st Jan Change
1.82 EUR -1.19% Intraday chart for Global Bioenergies +0.77% -8.91%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Global Bioenergies Partners with Shell on More Focused Development of Low-carbon Road Fuels MT
Global Bioenergies SA Announces Board Changes CI
Global Bioenergies: financial visibility extended CF
Global Bioenergies Hires Chief Business Officer MT
Global Bioenergies Announces the Appointment of Martin Stephan as Chief Business Officer CI
Global Bioenergies Secures EUR16 Million Government Funding for Biosourced Isobutene Plant MT
Global Bioenergies SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Global Bioenergies Launches Isonaturane® 16, Its Second Cosmetic Ingredient CI
Global markets live: Blackberry, Meta Platforms, Rivian, GM... Our Logo
Global markets live: Airbus, Walmart, Meta, Home Depot... Our Logo
Global Bioenergies, Shell Extend Renewable Road Fuels R&D Deal MT
Global Bioenergies Successfully Hits Milestone in Shell Collaboration and Signs Follow-On Agreement CI
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Global Bioenergies Scales Up Production at Pomacle Commercial Unit MT
Global Bioenergies Announces the Successful Scale-Up of Production At Its Pomacle Commercial Unit CI
Shell Teams Up With Global Bioenergies to Develop Low-Carbon Road Fuels MT
Global Bioenergies Agrees Collaboration with Shell in the Development of Low Carbon Road Fuels CI
Global Bioenergies Renews Equity Line With Kepler Cheuvreux MT
Global Bioenergies Jumps 7% on Completion of Residual Wood Conversion Project MT
Global Bioenergies SA Completes REWOFUEL Project CI
Spain's Repsol Orders Testing Volumes Of Global Bioenergies’ Bio-isobutene Derivatives MT
Global Bioenergies To Provide Shell With Testing Volumes Of Bio-isobutene Derivatives MT
Global Bioenergies Announces the Start of Production at its Pomacle Unit and Commercial Launch at In-Cosmetics in Paris CI
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chart Global Bioenergies
More charts
Global Bioenergies converts plant resources into compounds used in cosmetics, energy and materials. After launching the first long-lasting and natural make-up brand LAST® in 2021, Global Bioenergies is now marketing Isonaturane®12, its key ingredient, to major cosmetics companies to improve the naturalness of their formulations and their environmental footprint. Its process has numerous applications in specialty chemicals and polymers. Ultimately, Global Bioenergies aims to reduce CO2 emissions from air transport by developing sustainable fuels and thus contribute to limiting global warming.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.842 EUR
Average target price
4 EUR
Spread / Average Target
+117.16%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Global Bioenergies - Euronext Paris
  4. News Global Bioenergies
  5. Global Bioenergies To Provide Shell With Testing Volumes Of Bio-isobutene Derivatives